StockWatch
·
Specialty Chemicals
Quarterly Result19 Jun 2026, 04:40 pm

Crestchem approves Q4/FY26 results, recommends ₹1.50 dividend

AI Summary

Crestchem Ltd's Board of Directors approved the Audited Standalone & Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of ₹1.50 per equity share (15%) for FY2025-26, subject to shareholder approval at the upcoming 34th Annual General Meeting. The company also noted the formation of a new subsidiary, OLEO BIOSCIENCES PRIVATE LIMITED, and approved an investment of up to ₹2.25 Crores in it. Furthermore, the reappointments and remuneration of Mr. Dipak Narendraprasad Patel, Mrs. Parul Dipak Patel, and Mrs. Tansi Nirmit Patel for five-year terms were approved.

Key Highlights

  • Board approved Audited Standalone & Consolidated Financial Results for Q4/FY26.
  • Recommended a final dividend of ₹1.50 per equity share (15%) for FY2025-26.
  • Noted the formation of new subsidiary, OLEO BIOSCIENCES PRIVATE LIMITED.
  • Approved investment up to ₹2.25 Crores in the new subsidiary.
  • Reappointed three key management personnel/directors for five years.